Scientists create new probiotic to treat inflammatory bowel disease
科學家研發出治療發炎性腸道疾病的新型益生菌
更新於: 2026年6月20日 上午04:15
Scientists are making groundbreaking progress in treating Inflammatory Bowel Disease (IBD) by developing "engineered probiotics."
科學家正在透過開發「工程益生菌」在治療發炎性腸道疾病（IBD）方面取得突破性進展。
Unlike traditional supplements, these designer microbes use synthetic biology to act as living medicines.
與傳統補充劑不同，這些設計微生物利用合成生物學作為活體藥物。
By re-engineering bacteria like E. coli, researchers have created "smart" treatments that can survive in the harsh, inflamed conditions of an IBD patient's gut.
透過改造大腸桿菌（E. coli）等細菌，研究人員創造出能於發炎性腸道疾病患者腸道中嚴苛、發炎環境下存活的「智慧型」治療方式。
These microbes are programmed to sense inflammation in real-time, automatically releasing anti-inflammatory molecules or creating protective "band-aids" directly on damaged intestinal tissue.
這些微生物經程式編碼，能即時感知發炎，自動釋放抗發炎分子，或直接在受損的腸道組織上建立保護性的「OK繃」。
Beyond treatment, these probiotics could serve as living sensors, providing a non-invasive way to monitor gut health without frequent colonoscopies.
除了治療之外，這些益生菌還能作為活體感測器，提供一種無需頻繁進行大腸鏡檢查就能監測腸道健康的非侵入性方法。
By focusing on localized, site-specific healing, these therapeutics offer a promising alternative to systemic drugs that often cause widespread side effects.
這些治療法專注於局部、特定部位的療癒，為常引起廣泛副作用的全身性藥物提供了一種極具潛力的替代方案。
While the technology is still moving through clinical trials, it represents a shift toward personalized medicine.
雖然該技術仍在進行臨床試驗，但這象徵著朝向個人化醫療的轉變。
By customizing strains to match an individual's unique microbiome, scientists hope to restore balance to the gut, moving beyond merely masking symptoms to actively healing the digestive system from within.
透過訂製菌株以匹配個人獨特的微生物組，科學家期望能恢復腸道平衡，不僅僅是掩蓋症狀，而是從內部積極療癒消化系統。
